Dear Colleague
Please seeherefor your attention, letter from Dr McBride, Chief Medical Officer and letter from the four UK Chief Medical Officers here.
Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
Please see here for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management and Dr Stephen Bergin, Director of Public Health and Medical Director (Interim), PHA.
Summary
Action
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
Please see here for your attention, correspondence from Dr Michael McBride, Chief Medical Officer and Cathy Harrison, Chief Pharmaceutical Officer.
Summary
Action
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
Pharmacy team(s) can keep updated with drug information, alerts and shortages information via CPNI’s contractor calendar here or via the BSO website as per the links below.
Weekly Summary 04.12.20 |
Drug alerts available here: BSO Communications (Drug Alerts) MPS 2738 – Medicines Recall – Simvador 10mg, 20mg and 40mg tabs 3rd December 2020 |
Shortages Information available here: BSO Shortages Information MPS 2739 – Rifadin (Rifampicin) 100mg/5ml Oral Susp – Supply Alert 3rd December 2020 |
Please bring this to the attention of your pharmacy team(s).
Yours sincerely
Kerry
SENT FOR AND BEHALF OF KERRY GRIMES |Governance & Support Pharmacist
Dear Colleague
Please see correspondence for your attention, from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.
Letter_to_CPs_OTC_Stop_List_Letter.pdf
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
Please see below a letter for your attention from Dr Brid Farrell, Assistant Director of Service Development, Safety and Quality, PHA.
SUMMARY
A new antibody testing service that has been introduced into Northern Ireland as part of the UK Department of Health and Social Care (DHSC) antibody testing programme to support surveillance studies across the UK. The study will include the following group: those working in primary care (for example a GP, pharmacist, community nurse, dental nurse or optician). Further information on the testing and the seroprevalence study is included in the attached document.
ACTION
In order to participate, individuals must register for a test online through the GOV.UK website:
https://www.gov.uk/register-coronavirus-antibody-test
NB. Not all who register for a test may receive one.
Antibody_testing_letter_3.12.2020.pdf
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive